About this trial

A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness

Eligibility criteria

Qualifiers

Recipient Inclusion Criteria

Ability to give informed consent

Receiving FMT or other gut-related microbiota product within 90 days after providing consent

Access to internet and/or telephone

Disqualifiers

Incarceration

Trial design

Treatments tested in this trial

  • None - Observational

Treatment groups

No treatment groups listed

Locations

53
Canada
University of AlbertaT6G2X8, EdmontonAlberta, Canada
United States
Arizona
Phoenix Children's Hospital85016, Phoenix United States
California
Children's Hospital of Los Angeles90027, Los Angeles United States
University of California90095, Los Angeles United States

Sponsors and collaborators

American Gastroenterological Association

Lead sponsor

OpenBiome

Collaborator

University of California, San Diego

Collaborator

University of Pennsylvania

Collaborator

University of Minnesota

Collaborator

Loyola University Chicago

Collaborator

Commure, Inc

Collaborator